Thomas P. Hess

President, Chief Financial Officer at Organovo

Thomas P. Hess, CPA, MBA has extensive experience in the financial sector, particularly in the biotechnology and pharmaceutical industries. Thomas P. currently holds the position of President and Chief Financial Officer at Organovo Holdings, Inc. since October 2021. Prior to that, they served as the Chief Financial Officer at Hillstream BioPharma, Inc., where they played a crucial role in the company's initial public offering.

Mr. Hess has also worked at Danforth Advisors as the Chief Financial Officer and at Genomind, Inc. as the Senior Vice President and Chief Financial Officer. At Genomind, they contributed to the development of a precision healthcare platform for mental health patients. Thomas P. was also a Member of the Board of Directors at FSSolutions until its sale to Vault Health in May 2021.

Throughout their career, Mr. Hess has held various executive positions, including Interim Chief Executive Officer at Genomind, Inc. and Executive Vice President and Chief Financial Officer at Keane, where they managed financial and fiscal aspects of a large operation.

Their earlier experiences include serving as the Senior Vice President of Finance and Chief Financial Officer at Yaupon Therapeutics, Inc., where they played a key role in the sale of the company's asset, and as the Vice President of Finance and Chief Financial Officer at Adolor Corporation, where they directed a successful public offering.

Furthermore, Mr. Hess has demonstrated their financial expertise as the Corporate Controller at Vicuron Pharmaceuticals, a company focused on the development of drugs for serious bacterial and fungal infections.

Overall, Thomas P. Hess, CPA, MBA brings a wealth of financial leadership and experience to their role as a President and Chief Financial Officer, with a specific focus in the biotechnology and pharmaceutical sectors.

Thomas P. Hess, CPA, MBA, obtained their Bachelor of Science degree in Accounting from Penn State University between 1981 and 1985. Afterward, they pursued further education and completed their Master of Business Administration (MBA) in Finance at the University of Pittsburgh Katz Graduate School of Business between 1990 and 1994.

Additionally, Thomas obtained the Certified Public Accountant (CPA) certification from the Commonwealth of Pennsylvania in June 1987.

Links

Previous companies

Genomind logo

Timeline

  • President, Chief Financial Officer

    October, 2021 - present

View in org chart